Log In
Print
BCIQ
Print
Print this Print this
 

Architect AFP

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionChemiluminescent microparticle immunoassay (CMIA) that quantitatively determines alpha-fetoprotein (AFP) in human serum, plasma or amniotic fluid samples
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsAid in monitoring disease progression in patients with nonseminomatous testicular cancer and aid in the detection of fetal open neural tube defects (NTD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today